To validate the prediction of tamoxifen resistance via CAIX expression, we upregulated CAIX expression in MCF‐7 cells after tamoxifen treatment, and found that breast cancer cells became less sensitive to tamoxifen treatment after 24 hours (Figure 2C). The gene discussed is CA9; the disease is breast carcinoma.